Who is sponsoring NCT05200793?

NCT05200793 is sponsored by Alexandria University.

What drugs are being tested in NCT05200793?

Interventions in NCT05200793: Empagliflozin 25 mg, Linagliptin 10 mg, Metformin 1500 mg.

What condition does NCT05200793 study?

NCT05200793 studies Polycystic Ovary Syndrome (PCOS).

Is NCT05200793 still recruiting?

NCT05200793 is currently status unknown. Last updated 21 January 2022.

Last reviewed 2022-01-21 · How we verify

NCT05200793

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome

Status unknown Phase 4 Last updated 21 January 2022

What this trial tests

Phase 4 trial testing Empagliflozin 25 mg in Polycystic Ovary Syndrome (PCOS) in 75 participants. Status unknown.

Timeline

7 December 2021

Primary endpoint
1 July 2022

1 September 2022

Quick facts

Lead sponsor	Alexandria University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	75
Start date	7 December 2021
Primary completion	1 July 2022
Estimated completion	1 September 2022
Sites	1 location across Egypt

Drugs / interventions tested

Empagliflozin 25 mg — full drug profile →
Linagliptin 10 mg — full drug profile →
Metformin 1500 mg — full drug profile →

Conditions studied

Polycystic Ovary Syndrome (PCOS) — all drugs for Polycystic Ovary Syndrome (PCOS) →

Sponsor

Alexandria University

Who can join

Adults 18 to 40, female only, with Polycystic Ovary Syndrome (PCOS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to compare the efficacy of Empagliflozin or Linagliptin as an alternative to Metformin for treatment of non-diabetic patients with polycystic ovary syndrome (PCOS).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Polycystic ovary syndrome: pathophysiology and therapeutic opportunities.
Dong J, Rees DA. · · 2023 · cited 44× · PMID 37859784 · DOI 10.1136/bmjmed-2023-000548
Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy.
Colbert GB, Madariaga HM, Gaddy A, Elrggal ME, et al · · 2023 · cited 3× · PMID 36756278 · DOI 10.2147/tcrm.s398163

Verify or expand the search:

Other trials of Empagliflozin 25 mg

Trials testing the same drug.

NCT05512130 — Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy · EARLY_PHASE1 · unknown
NCT04049045 — Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure · Phase 2 · completed

Other recruiting trials for Polycystic Ovary Syndrome (PCOS)

Currently open trials in the same condition.

NCT07298564 — Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS · NA · recruiting
NCT07394530 — Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS · NA · recruiting
NCT07371364 — Mobile Application for Women With Polycystic Ovary Syndrome · NA · active not recruiting
NCT07242131 — Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS · NA · recruiting
NCT07171970 — IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women · NA · recruiting

Other Alexandria University trials

Trials by the same sponsor.

NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05200793 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexandria University
Last refreshed: 21 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05200793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing